The HGF-MET signaling has been extensively reported to participate in the tumorigenesis, metabolism and metastasis of various cancers, and multiple HGF-MET pathway inhibitors exhibited potent anti-cancer role by preventing tumor metastasis (Huang et al., 2019; Yin et al., 2019; Shi et al., 2021). Here, MET is linked to cancer.